Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-17Clinical Trial Update: Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours (Elios-Color-on-Specimen) [NA]
The Elios-Color-on-Specimen trial evaluating endoscopic optical imaging for precision oncology in colorectal tumors has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-04-09Clinical Trial Update: Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study
The CLEAR study evaluating colorectal lesion evaluation and appropriate resolution has been terminated.
-
CLINICAL_TRIALS withdrawal · 2026-04-06Clinical Trial Update: Study of NGM707 in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies [Phase 2]
A Phase 2 trial of NGM707 in combination with pembrolizumab for advanced or metastatic solid tumors, including colorectal cancer, has been w…
-
CLINICAL_TRIALS withdrawal · 2026-04-06Clinical Trial Update: Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer [Phase 2]
Phase 2 trial of Monalizumab and MEDI5752 in MSI/dMMR metastatic colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-04-03Clinical Trial Update: Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
The ECOG-ACRIN trial assessing biomarker testing practices for common solid cancers in community oncology settings has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2026-03-11Clinical Trial Update: A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer [Phase 1, Phase 2]
Clinical trial evaluating regorafenib plus lorigerlimab as neoadjuvant therapy for colorectal cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-25Clinical Trial Update: Behavioral Nudge in Colorectal Cancer Screening [NA]
Trial NCT06796049, evaluating behavioral nudges to increase fecal immunochemical test completion for colorectal cancer screening, has been w…
-
CLINICAL_TRIALS withdrawal · 2026-02-19Clinical Trial Update: Immunotherapies in Combination With Stereotactic Body Radiation Radiotherapy in Microsatellite Stable (MSS) Metastatic Colorectal Cancer (mCRC) [Phase 2]
A Phase 2 trial evaluating immunotherapies in combination with stereotactic body radiotherapy for microsatellite stable metastatic colorecta…
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs [NA]
A clinical trial evaluating an individual decision aid for colorectal, breast, and ovarian cancer screening in Sweden has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-11Clinical Trial Update: Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial investigating 5-fluorouracil for metastatic colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-09Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Inavolisib When Administered in Combination With Bevacizumab and FOLFOX or FOLFIRI as First Line Therapy in Participants With Colorectal Cancer [Phase 2]
Phase 2 trial evaluating Inavolisib in combination with Bevacizumab and FOLFOX or FOLFIRI as first-line therapy in colorectal cancer has bee…
-
CLINICAL_TRIALS withdrawal · 2026-02-06Clinical Trial Update: Living Donor Liver Transplantation for CRC Liver Metastases [NA]
A clinical trial evaluating living donor liver transplantation for colorectal cancer with liver metastases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-01-16Clinical Trial Update: Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?
The clinical trial evaluating whether genetic susceptibility to bleeding affects quantitative faecal immunochemical test (qFIT) results for …
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer [Phase 1]
A Phase 1 study evaluating select drug combinations in adult patients with advanced/metastatic BRAF V600 colorectal cancer has been terminat…
-
CLINICAL_TRIALS withdrawal · 2025-12-24Clinical Trial Update: STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma [Phase 1]
A Phase 1 study of STIL101 for injection across pancreatic ductal adenocarcinoma, colorectal cancer, renal cell carcinoma, cervical cancer, …
-
CLINICAL_TRIALS withdrawal · 2025-12-18Clinical Trial Update: M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511) [Phase 1]
Phase 1 study of M9466 in combination with Topoisomerase 1 inhibitors for advanced solid tumors, including colorectal cancer, was terminated…
-
CLINICAL_TRIALS withdrawal · 2025-10-21Clinical Trial Update: Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial combining AlloStim with an anti-PD-L1 agent for fourth-line metastatic microsatellite-stable colorectal cancer has been with…
-
CLINICAL_TRIALS withdrawal · 2025-10-06Clinical Trial Update: CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating CBX-12 for metastatic colorectal cancer that is mismatch repair proficient has been withdrawn, with no ongoing en…
-
CLINICAL_TRIALS withdrawal · 2025-09-26Clinical Trial Update: Metabiomics Colon Cancer Clinical Research Study
Metabiomics Corp's colon cancer clinical trial (NCT02151123) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-18Clinical Trial Update: Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer [Phase 1, Phase 2]
Clinical trial of intra-arterial oxaliplatin plus capecitabine for liver metastases from colorectal cancer has been terminated (Phase 1/Phas…
-
CLINICAL_TRIALS withdrawal · 2025-09-11Clinical Trial Update: A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies [Phase 2]
A Phase II clinical trial investigating adjuvant immunotherapy targeting KRAS G12D, KRAS G12V, and TP53 R175H across several gastrointestina…
-
CLINICAL_TRIALS withdrawal · 2025-09-11Clinical Trial Update: A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer [Phase 2]
A Phase II study evaluating an organ-preservation strategy using immune checkpoint blockade for primary colorectal or gastroesophageal cance…
-
CLINICAL_TRIALS withdrawal · 2025-09-05Clinical Trial Update: LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating LY3200882 in combination with capecitabine for advanced, TGF-beta-activated colorectal cancer has been…
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9 [Phase 1]
Phase 1 trial evaluating PET imaging agents 64Cu-Tz-SarAr and hu5B1-TCO in pancreatic, colorectal, and bladder cancers (including cancers wi…
-
CLINICAL_TRIALS withdrawal · 2025-09-02Clinical Trial Update: Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures [Phase 2]
Phase 2 trial targeting MDMD and PD-1 in tumors with tertiary lymphoid structures has been withdrawn; the study covered soft tissue sarcoma,…